http://diabetes.org/diabetesnewsarticle.jsp?storyId=16715004&filename=20080104/r
euters20080104health00000020reutershealthewEDIT.xml

or

http://tinyurl.com/ywrr39

NEW YORK (Reuters Health) - As a treatment for heart disease in
diabetics, stents that release sirolimus, an immune-suppressing drug,
are more effective than those that release paclitaxel, a cancer-
fighting drug, for keeping coronary arteries open after angioplasty,
new research shows.

A stent is a tiny hollow tube that is placed in the coronary arteries
to maintain blood flow after the blood vessel has been dilated with
angioplasty. In the past, stents were simply made out of metal and did
not release any drugs. In recent years, there has been evidence that
the so-called "drug-eluting" stents are superior to bare metal ones.

The optimal drug-eluting stent for diabetic patients has been unclear,
lead author Dr. Fabrizio Tomai, from the European Hospital in Rome,
and colleagues note in the journal Diabetes Care.